Literature DB >> 29862889

Effect of Mode of Conception on Maternal Serum Relaxin, Creatinine, and Sodium Concentrations in an Infertile Population.

Frauke von Versen-Höynck1,2, Nairi K Strauch1, Jing Liu3, Yueh-Yun Chi3, Maureen Keller-Woods4, Kirk P Conrad5,6, Valerie L Baker1.   

Abstract

OBJECTIVE: To investigate how the mode of conception affects maternal relaxin, creatinine, and electrolyte concentrations.
BACKGROUND: Pregnancies achieved by fertility treatment often begin in a nonphysiologic endocrine milieu with no corpus luteum (CL) or with many corpora lutea. The CL produces not only estradiol and progesterone but is also the sole source of relaxin in early pregnancy, a hormone that may contribute to maternal systemic and renal vasodilation. There is limited data about maternal physiology in early pregnancy during fertility treatment, and studies have rarely considered the potential effect of the absence of the CL. To begin to address this gap in knowledge, we sought to investigate how the mode of conception affects maternal relaxin, creatinine, and electrolyte concentrations.
METHODS: One hundred eighty-four women who received care at an academic infertility practice provided serum samples. Levels of relaxin 2, creatinine, and electrolytes were compared between 4 groups defined on the basis of mode of conception which corresponded to categories of CL number: (1) absence of the CL, (2) single CL, (3) multiple CL from ovarian stimulation not including in vitro fertilization (IVF), and (4) multiple CL from IVF with fresh embryo transfer.
RESULTS: Relaxin-2 levels were undetectable in patients lacking a CL. Creatinine, sodium, and total CO2 levels were significantly higher in the 0 CL group (relaxin absent) compared to all other groups (relaxin present). Compared to clomiphene, use of letrozole was associated with a lower relaxin level.
CONCLUSION: Early creatinine and sodium concentrations are increased in the absence of relaxin. Given the increasing utilization of frozen embryo transfer, further studies comparing programmed with natural cycles are warranted.

Entities:  

Keywords:  assisted reproduction; corpus luteum; female infertility; pregnancy; relaxin

Mesh:

Substances:

Year:  2018        PMID: 29862889      PMCID: PMC6728556          DOI: 10.1177/1933719118776792

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  42 in total

1.  Relaxin is a potent renal vasodilator in conscious rats.

Authors:  L A Danielson; O D Sherwood; K P Conrad
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

2.  Relaxin is essential for renal vasodilation during pregnancy in conscious rats.

Authors:  J Novak; L A Danielson; L J Kerchner; O D Sherwood; R J Ramirez; P A Moalli; K P Conrad
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 3.  Relaxin's physiological roles and other diverse actions.

Authors:  O David Sherwood
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

4.  Immunocytochemical localization of relaxin in human corpora lutea: cellular and subcellular distribution and dependence on reproductive state.

Authors:  E Stoelk; N Chegini; Z M Lei; C V Rao; G Bryant-Greenwood; J Sanfilippo
Journal:  Biol Reprod       Date:  1991-06       Impact factor: 4.285

5.  Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats.

Authors:  Dan O Debrah; Jackie Novak; Julianna E Matthews; Rolando J Ramirez; Sanjeev G Shroff; Kirk P Conrad
Journal:  Endocrinology       Date:  2006-07-27       Impact factor: 4.736

6.  Relaxin has a role in establishing a renal response in pregnancy.

Authors:  Marie C Smith; Alison P Murdoch; Lee A Danielson; Kirk P Conrad; John M Davison
Journal:  Fertil Steril       Date:  2006-05-30       Impact factor: 7.329

7.  Maternal central hemodynamics in hypertensive disorders of pregnancy.

Authors:  P M Bosio; P J McKenna; R Conroy; C O'Herlihy
Journal:  Obstet Gynecol       Date:  1999-12       Impact factor: 7.661

8.  Human chorionic gonadotropin stimulation of relaxin secretion by luteinized human granulosa cells.

Authors:  C L Gagliardi; L T Goldsmith; M Saketos; G Weiss; C L Schmidt
Journal:  Fertil Steril       Date:  1992-08       Impact factor: 7.329

9.  Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers.

Authors:  Marie C Smith; Lee A Danielson; Kirk P Conrad; John M Davison
Journal:  J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 10.121

10.  Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats.

Authors:  Kirk P Conrad; Dan O Debrah; Jackie Novak; Lee A Danielson; Sanjeev G Shroff
Journal:  Endocrinology       Date:  2004-07       Impact factor: 4.736

View more
  18 in total

Review 1.  Evidence for Corpus Luteal and Endometrial Origins of Adverse Pregnancy Outcomes in Women Conceiving with or Without Assisted Reproduction.

Authors:  Kirk P Conrad
Journal:  Obstet Gynecol Clin North Am       Date:  2020-03       Impact factor: 2.844

2.  Vascular Health of Children Conceived via In Vitro Fertilization.

Authors:  Wendy Y Zhang; Elif Seda Selamet Tierney; Angela C Chen; Albee Y Ling; Raquel R Fleischmann; Valerie L Baker
Journal:  J Pediatr       Date:  2019-08-20       Impact factor: 4.406

3.  Maternal Cardiovascular Dysregulation During Early Pregnancy After In Vitro Fertilization Cycles in the Absence of a Corpus Luteum.

Authors:  Kirk P Conrad; John W Petersen; Yueh-Yun Chi; Xiaoman Zhai; Minjie Li; Kuei-Hsun Chiu; Jing Liu; Melissa D Lingis; R Stan Williams; Alice Rhoton-Vlasak; Joseph J Larocca; Wilmer W Nichols; Mark S Segal
Journal:  Hypertension       Date:  2019-07-29       Impact factor: 10.190

4.  Endometrial thickness is an independent risk factor of hypertensive disorders of pregnancy: a retrospective study of 13,458 patients in frozen-thawed embryo transfers.

Authors:  Meng Zhang; Jing Li; Xiao Fu; Yiting Zhang; Tao Zhang; Bingjie Wu; Xinyue Han; Shanshan Gao
Journal:  Reprod Biol Endocrinol       Date:  2022-06-28       Impact factor: 4.982

Review 5.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

6.  Fresh versus frozen embryo transfers in assisted reproduction.

Authors:  Tjitske Zaat; Miriam Zagers; Femke Mol; Mariëtte Goddijn; Madelon van Wely; Sebastiaan Mastenbroek
Journal:  Cochrane Database Syst Rev       Date:  2021-02-04

7.  Is a frozen embryo transfer in a programmed cycle really the best option?

Authors:  Valerie L Baker; Ijeoma Iko; James Segars
Journal:  J Assist Reprod Genet       Date:  2019-04-13       Impact factor: 3.357

8.  Endometrial preparation for frozen-thawed embryo transfer cycles: a systematic review and network meta-analysis.

Authors:  Hanglin Wu; Ping Zhou; Xiaona Lin; Shasha Wang; Songying Zhang
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

9.  Maternal Vascular Health in Pregnancy and Postpartum After Assisted Reproduction.

Authors:  Frauke von Versen-Höynck; Sebastian Häckl; Elif Seda Selamet Tierney; Kirk P Conrad; Valerie L Baker; Virginia D Winn
Journal:  Hypertension       Date:  2019-12-16       Impact factor: 10.190

10.  Determinants of Maternal Renin-Angiotensin-Aldosterone-System Activation in Early Pregnancy: Insights From 2 Cohorts.

Authors:  Rosalieke E Wiegel; A H Jan Danser; Régine P M Steegers-Theunissen; Joop S E Laven; Sten P Willemsen; Valerie L Baker; Eric A P Steegers; Frauke von Versen-Höynck
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.